✦ LIBER ✦

Incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder

✍ Scribed by R. Sanchez; E. Kim; J. Eudicone; A. Pikalov; E. Vester-Blokland; D.D. Miller

Book ID: 118438246
Publisher: Elsevier Science
Year: 2007
Tongue: French
Weight: 46 KB
Volume: 22
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2007.01.443

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of tardive dyskinesia is lower

Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizoaffective disorder

✍ W.M. Glazer; H. Morgenstern; J.A. Pultz; P.P. Yeung; I.W. Rak 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Intramuscular aripiprazole for the treat

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

✍ Raisa Andrezina; Richard C. Josiassen; Ronald N. Marcus; Dan A. Oren; George Man 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 262 KB

Long-term efficacy and safety of aripipr

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study

✍ Jun Soo Kwon; Joon Hwan Jang; Do-Hyung Kang; So Young Yoo; Yong Ku Kim; Seong-Ji 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

P.3.c.040 The comparison of efficacy bet

P.3.c.040 The comparison of efficacy between aripiprazole and haloperidol in treatment of chronic schizophrenia and schizoaffective disorder: results for 16-week clinical study

✍ J.G. Kim; D.H. Cho; S.J. Lee; J.K. Lee; K.S. Wang; Y.I. Seo; S.J. Choi; M.J. Joo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 76 KB

LONG-TERM TOLERABILITY AND SAFETY OF ARI

LONG-TERM TOLERABILITY AND SAFETY OF ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER

✍ Margaretta Nyilas; Robert Forbes; Na Jin; Catherine Aurang; Brian Jonhnson; Rand 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

An observational study of the effectiven

An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder

✍ Franca Centorrino; Adam L. Meyers; Jonna Ahl; Stephanie L. Cincotta; Leslie Zun; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## Objective To determine the effect of intramuscular (IM) olanzapine in severely agitated patients. ## Methods This was an open‐label multicenter 1‐week observational study of IM olanzapine treatment in severely agitated inpatients and psychiatric emergency services with bipolar man